Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Checkpoint inhibitors”
Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
ClinicalTrials.gov study NCT05062395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05544149. IPD Sharing: NO. Countries: 1. Publications: 0.
Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside
ClinicalTrials.gov study NCT06020651. IPD Sharing: NO. Countries: 1. Publications: 0.
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
ClinicalTrials.gov study NCT06422403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT06738797. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05653531. IPD Sharing: NO. Countries: 1. Publications: 0.
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
ClinicalTrials.gov study NCT05967533. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
ClinicalTrials.gov study NCT04407247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
ClinicalTrials.gov study NCT06107608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT06581406. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT07191171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer
ClinicalTrials.gov study NCT05655663. IPD Sharing: NO. Countries: 1. Publications: 0.
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial
ClinicalTrials.gov study NCT06438588. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or
ClinicalTrials.gov study NCT05867121. IPD Sharing: NO. Countries: 9. Publications: 0.
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT05101070. IPD Sharing: NO. Countries: 2. Publications: 0.
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04137588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tum
ClinicalTrials.gov study NCT05581004. IPD Sharing: NO. Countries: 10. Publications: 0.
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of E
ClinicalTrials.gov study NCT06951841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Occurrence of Adverse Effects With Immune Checkpoint Inhibitors Between a Single and Double Dose Regimen
ClinicalTrials.gov study NCT04956783. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT03161756. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.